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Abstract: This study aimed to ascertain the antioxidant and hypoglycemic 
activity of methanolic extracts of the leaves of Terminalia arjuna, T. bellerica, 
and T. chebula. Extracts were evaluated for total phenolic, flavonoid, and 
tannin content, and in vitro antioxidant potential with DPPH, ORAC, and 
FRAP assays. The extracts' hypoglycemic activities were evaluated by 
hypoglycemic screening and an oral glucose tolerance test (OGTT) in normal 
rats. The methanolic extracts of T. chebula leaves exhibited the highest 
quantity of total phenolic and flavonoid content, followed by those of T. 
bellerica and T. arjuna. T. arjuna contained more tannin than T. bellerica did, 
but less than that of T. chebula. The scavenging capacity of T. chebula for the 
antioxidant DPPH was the highest of the extracts tested, as it recorded the 
lowest IC50 value of all 3 extracts. Likewise, the results attributed the T. 
chebula extract with the highest oxygen radical absorption capacity (ORAC). 
In the FRAP assay, the extracts’ ferric reducing antioxidant abilities were T. 
arjuna > T. chebula > T. bellerica. This correlates the potential of 
polyphenolic content enriched with antioxidant capabilities and substantiates 
the results of the hypoglycemic screening and OGTT, which determined that 
the T. chebula extract had a better hypoglycemic effect in normal and glucose-
induced hyperglycemic rats (p <0.001) than that of T. bellerica and T. arjuna, 
respectively. The use of these Terminalia species as food supplements may 
help in reducing oxidative stress and related diabetic complications. The 
phytoconstituents responsible for the hypoglycemic activity need to be isolated 
to elucidate the relationship between the extracts’ antioxidant capacity and 
their hypoglycemic effects. 
Keywords: Polyphenols, Antioxidant activity, Hypoglycemic activity, Oral glucose tolerance test, 
Terminalia chebula. 
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Introduction 
The use of natural products as antioxidants in the management of diabetes mellitus has 
gained importance throughout the world. There has been increasing research focused on 
natural foods and medicinal plants and their phytoconstituents due to their well-known 
abilities to scavenge free radicals, i.e., antioxidative ability
1-3
.
 
The interest in natural 
antioxidants has burgeoned since evidence of their potential interference in the production of 
reactive oxygen species (ROS) was uncovered, these ROS plays an important role in the 
progression of a great number of pathological disturbances such as inflammation, 
atherosclerosis, stroke, heart disease, diabetes mellitus, multiple sclerosis, cancer, 
Parkinson’s disease, Alzheimer’s disease, etc4-5. 
 
 The world health organization has also recommended and encouraged the use of natural 
products for the management of diabetes and in oxidative stress conditions, especially in 
countries where access to conventional treatment of diabetes is inadequate. There is an 
increased demand for natural products with antidiabetic activity due to the side effects 
associated with the use of insulin and oral hypoglycemic agents
6
. 
 
 Natural antioxidants such as flavonoids and polyphenols are believed to possess 
antioxidant properties due to their reducing and chelating capabilities. Flavonoids and 
polyphenols are secondary plant metabolites that are widely distributed in fruits, leaves, 
bark, and other parts in plants with free radical scavenging abilities
7
. The genus Terminalia 
(fam. Combretaceae), comprising 250 species, is distributed across tropical countries 
worldwide, and the Indian traditional system of medicine has documented several books and 
literatures on the medicinal values of many of its species, of which Terminalia bellerica, T. 
chebula and T. arjuna are prime examples
8-9
. It has been reported that these species are rich 
in flavonoids and polyphenols. In “Ayurveda,” a herbal formulation combining the dried 
fruits of T. chebula, T. bellerica and Emblica officinalis by the name of “Triphala” has been 
used as a food and dietary supplement to derive several health benefits such as laxation, 
detoxification, liver protection, anti-aging, and as a rejuvenator of the body
10-11
. The 
combination has also been found to have antidiabetic and cholesterol-lowering activities
12-13
. 
The fruit extracts of T. chebula and T. bellerica have been shown to contain antioxidants
14
, 
and T. arjuna bark extracts have been reported to possess cardioprotective, antioxidant, and 
antimutagenic abilities
15-17
. Despite reports of the antioxidant and antidiabetic activities of 
the fruit and bark of Terminalia species, which are a rich source of flavonoids, tannins, and 
many phenolic derivatives, concrete evidence supporting the relationship with regard to the 
leaves of the genus is lacking.  
 
 Therefore, the present study was planned to investigate methanolic leaf extracts of the 3 
popular species to determine their total phenolic (TPC), total flavonoid (TFC), and total 
tannin content (TTC), as well as their 1,1-Diphenyl-2-picrylhydrazyl (DPPH) scavenging 
activity, oxygen radical antioxidant capacity (ORAC), and ferric reducing antioxidant power 
(FRAP) in correlation to their hypoglycemic activity. 
 
Experimental 
Dried powdered leaves of T. arjuna, T. bellerica, and T. chebula were obtained from 
Amritum Bio-Botanica Herbs Research Laboratory Pvt. Ltd, Jogli, India. These samples 
were successively defatted with hexane, then chloroform, and finally with methanol using a 
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Soxhlet apparatus. The resulting methanol extracts were evaporated under reduced pressure 
at 40°C using a rotary evaporator to derive a crude methanol (MeOH) extract that was 
further lyophilized and stored at -20°C prior to use.  
 
Determination of Total Phenolic and Flavonoid Content 
The TPC and TFC of the methanolic extracts were determined by the Folin-Ciocalteu and 
Dowd methods as adapted by Lamien-Meda et al
18
. Results are expressed as mg Gallic Acid 
equivalents (GAE) and mg Quercetin (Q) equivalents. 
Determination of Total Tannin Content 
The TTC in the methanolic extracts was estimated with the method by Price and Butler
19
 
with some modifications. A 3.0 mL volume of the sample, 3.0 mL of vanillin (4%) in 
methanol and 1.5 mL con. HCl were mixed and were incubated in the dark for 10 min. 
Subsequently, the TTC content of the samples were analyzed with a UV-Vis. 
spectrophotometer at 500 nm. Results are expressed as mg Catechin (C) equivalents. 
In vitro antioxidant study 
DPPH Radical Scavenging Activity  
The scavenging activity of all the 3 methanolic extracts on DPPH (1,1-diphenyl-2-
picrylhydrazyl) was determined using the method described by Choi et al 
20 
with 
slight modifications. This method is based on the reduction of purple DPPH to a 
yellow colored diphenylpicrylhydrazine. Changes in color were measured at 518 nm. 
All the extracts were tested at final concentrations ranging 600–10 µg/mL in ethanol. 
One milliliter of 0.3 mM DPPH ethanol solution was added to 2.5 mL of sample 
solution in different concentrations to produce the test solutions, while 1 mL of 
ethanol was added to 2.5 mL of sample to produce the blank solutions. The negative 
control consisted of 1 mL of DPPH solution plus 2.5 mL of ethanol. The solutions 
were allowed to react at room temperature for 30 min in the dark. The absorbance 
values were measured at 518 nm and converted into percentage antioxidant activity 
using the following equation: 
 
% Inhibition = [(AB - AA)/AB] × 100, 
 
where AB: absorption of blank sample; AA: absorption of tested samples. The half maximal 
inhibitory concentration (IC50) and the kinetics of DPPH scavenging activity were 
determined. Ascorbic acid and butylated hydroxytoluene (BHT) were used as positive 
controls in this assay.  
ORAC Antioxidant Activity Assay 
The oxygen radical absorbance capacity (ORAC) assay was carried out based on the 
procedure described by Cao G et al
21
 with slight modifications. Briefly, 175 µL of the 
sample/blank were dissolved with PBS at concentrations of 160 µg/mL, pH 7.4. Serial 
dilutions of the standard Trolox were prepared from 75 mM. The assay was performed in 
96-well black microplates, to which 25 µL each of samples (extracts), standard (Trolox), 
blank (solvent/PBS), or positive control (quercetin) were added. Subsequently, 150 µL of 
fluorescent sodium salt solution was added, and the plate was incubated for 45 minutes at  
37°C. 2,20-azobis (2-amidinopropane) dihydrochloride (AAPH) solution (25 µL) was added 
to make up a total volume of 200 µL/well. Fluorescence was recorded at 37°C until it 
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reached 0 (excitation at 485 nm, emission at 535 nm) using a fluorescence 
spectrophotometer (Perkin-Elmer LS 55) equipped with an automatic thermostatic autocell-
holder. Data were collected every 2 min for 2 h and were analyzed by calculating the 
differences of areas under the fluorescein decay curve (AUC) between the blank and the 
sample. Values are expressed as Trolox equivalents. 
FRAP Assay 
The FRAP (ferric reducing/antioxidant power) assay was modified from the method used 
by Benzie and Strain
22
. The stock solutions included 300 mM acetate buffer (pH 3.6),         
10 mM TPTZ (2,4,6-tripyridyl-s-triazine) solution in 40 mM HCl and 20 mM FeCl3·6H2O 
solution. A fresh working solution was prepared by mixing 25 mL acetate buffer, 2.5 mL 
TPTZ, and 2.5 mL FeCl3·6H2O. The temperature of the solution was raised to 37°C before 
use. Extracts (10 μL) were allowed to react with 190 μL of FRAP solution for 30 min in 
the dark. Colorimetric readings of the product, i.e., the ferrous-TPTZ complex, were taken 
at 593 nm for 10 min and a steady state was reached within 5 min for the different test 
substance concentrations. The EC1 value was calculated from the regression curve as the 
concentration of antioxidant (lM) giving an absorbance reading equivalent to that obtained 
with a 1 mM Fe(II) solution. The standard curve was linear between 200 and 1000 μM 
FeSO4. Results are expressed as μM Fe (II)/g dry mass and compared with those of 
ascorbic acid and BHT. 
In Vivo Study 
Animals and Treatment 
Male Sprague-Dawley rats weighing 200–250 g were procured from the Animal Care Unit 
of the University Malaya Medical Centre (UMMC) in Kuala Lumpur, Malaysia and 
maintained under pathogen-free conditions in the animal housing unit in a temperature-       
(23±2°C) and light-controlled (12 h light/dark cycle) room with 35–60% humidity. Animals 
were provided with carbohydrate-enriched rodent chow and water ad libitum. The Animal 
Ethics Committee from the UMMC Faculty of Medicine approved the study under Approval 
No. FAR/10/11/2008/AA(R).  
Acute Oral Toxicity  
The acute oral toxicity test of the 3 plants’ methanolic extracts was planned according to the 
Organization for Economic Co-operation and Development (OECD) guidelines. Healthy 
male Sprague-Dawley rats weighing 150–200 g were used for this study. After an overnight 
fast, the rats were divided into 6 groups (n = 9–10) and orally fed with the methanolic leaf 
extracts. Three groups were fed with doses of 50 mg/kg body weight and the other 3 groups 
were fed doses of 2500 mg/kg body weight. The rats were observed continuously for 24 h 
for any behavioral, neurological, and autonomic profiles, and after 72 h for any lethality. 
According to this toxicity study, 1/10 of the maximum dose administered was used for the 
hypoglycemic screening study. 
Determination of Postprandial Blood Glucose Levels in Normal Rats  
Animals were divided into 5 groups of 8–9 in a group. One group was used as a positive 
control and received glibenclamide (5 mg/kg) orally; the negative control group received 
NaCl (0.9%, dose 2 mL/200 g), while the other 3 groups received methanolic leaf extracts 
(250 mg/kg). The lyophilized powder of all leaf extracts was reconstituted with filtered 
water and administered orally using a gavage (2 mL/200 g body weight). Blood samples 
were obtained by amputation of the tail tip in non-fasting conditions after 2, 4 and 6 h of 
treatment. Glycemia was determined using the glucose oxidase-peroxidase enzymatic 
method (Accu-Check Performa, Roche Diagnostic Germany) through electronic glucometer. 
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An extract was deemed to have a hypoglycemic effect if the blood glucose levels of the rats 
decreased significantly compared to those of the normal control group
23
.  
Glucose Challenge (Glucose Tolerance Test) 
An oral glucose tolerance test (OGTT) was used to evaluate the effectiveness of the leaf 
extracts with hypoglycemic potential on glucose induced hyperglycemic rats, which was 
derived from prior screening tests and from which the positive results formed the basis of 
this hypoglycemic screening. In rats fasted overnight, extracts (250 mg/kg) were fed in 
doses of 2.0 mL/200 g body weight and the control group was given NaCl (0.9%). 
Concentration of glucose level in blood was measured before and 120 min after extracts 
administration. After this time point, glucose (3 g/kg) was introduced orally, then glucose 
concentration in blood was measured at 30, 60 and 120 min post-challenge
23
. 
Statistical Analysis 
The data are expressed as the mean ±SD of 3 measurements. Statistical analysis was 
performed using one-way and two-way repeated measures ANOVA and comparison of the 
data was done by Tukey’s test with all pair-wise multiple comparison procedures. p <0.001 
was considered statistically significant. 
Results and Discussion 
In this study, we evaluated the total phenolic, total flavonoid, and total tannin content in the 
methanolic extract of T. chebula, T. bellerica and T. arjuna leaves, followed by evaluation 
of the extracts’ antioxidant activities and in vivo hypoglycemic screening in normal rats.  
Total Phenolic, Flavonoid and Tannin Content 
There has been an increased desire in consumers for functional foods with antioxidant 
capabilities. The fruit and leafy parts of plants are considered rich in polyphenols and 
flavonoids, which contributes to their antioxidant capacity
24
. The antioxidant property 
of phenolic compounds is attributed to their ability to absorb and neutralize free 
radicals. 
 The results in Table 1 demonstrate that the methanolic extract of T. chebula leaves 
contained the highest TPC, followed by those of T. bellerica and T. arjuna (266.16, 259.28, 
and 147.23 mg GAE/g extract, respectively), likewise, the TFC were 29.23, 16.15, and 8.19 
mg Q/g extract, respectively. T. chebula possessed the highest TTC, followed by T. arjuna 
and T. bellerica (8.36, 4.68 and 6.31 mg C/g extract, respectively). T. chebula fruits have 
been found to contain higher amounts of total phenolics, total flavonoids and total tannin, 
and are reported to contain gallic acid, chebulic acid, 1,6-di-O-galloyl-β-D-glucose, 
punicalagin,3,4,6-tri-O-galloyl-β-D-glucose, casuarinin, chebulanin, chebulagic acid, 
chebulinic acid and 1,2,3,4,6-penta-O-galloyl-β-D-glucosein, which might be responsible for 
its high antioxidant activity
25
. 
 
Table 1. Total phenolic, flavonoid, and tannin content in methanolic extracts of Terminalia 
chebula, T. bellerica, and T. arjuna leaves. 
No. Plants 
Total Phenolic 
Content
a 
(mg GAE/g 
extract) 
Total Flavonoid 
Content
a 
(mg 
Quercetin/g extract) 
Total Tannin 
Content
a 
(mg 
Catechin/g extract) 
1 T. chebula 266.16 ± 7.81 29.23 ± 3.81 8.36 ± 0.37 
2 T. bellerica 259.28 ± 6.42 16.15 ± 2.42 4.68 ± 1.31 
3 T. arjuna 147.23 ± 2.34 8.19 ± 1.41 6.31 ± 0.17 
aValues expressed are mean ± SD of triplicate measurements. 
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In Vitro Antioxidant Activities 
The antioxidant activities of the T. chebula, T. bellerica and T. arjuna leaf extracts were 
determined with DPPH, ORAC and FRAP assays. These assays were measured in triplicate 
at different concentrations to determine the extracts’ IC50 values. The results are listed in 
Table 2.  
DPPH Radical Scavenging Activity 
The DPPH radical is used commonly and extensively to determine the in vitro antioxidative 
activity of antioxidant compounds. When treated with substances or samples that are 
hydrogen atom donors, the DPPH radical is converted into a stable DPPH radical, indicated 
by a color change from purple to yellow (Kriengsak Thaipong, 2006). DPPH radical 
reduction is analyzed by measuring the absorbance of samples at a 518 nm wavelength. The 
DPPH scavenging capacity of T. chebula (11.6 µg/mL) was the highest of the 3 extracts 
tested, as it recorded the lowest IC50 value of all the extracts, while T. bellerica                 
(16.4 µg/mL) demonstrated better scavenging activity than T. arjuna (21.8 µg/mL) did. 
Among the positive controls, ascorbic acid (1.6 µg/mL) was found to have better DPPH 
radical scavenging ability than BHT (1.7 µg/mL). Flavonoids are well-known antioxidant 
constituents of plants and possess a broad spectrum of chemical and biological activities, 
including radical-scavenging or chelating activities
26
. 
ORAC Assay 
All the extracts demonstrated good oxygen radical absorption capacity; IC50 values are 
expressed in Trolox (μM/mL) equivalent (TE) concentrations as listed in Table 2. T. chebula 
exhibited lower IC50 values (18.23 μM TE/mL) than the other 2 species did. T. arjuna had an 
IC50 value of 42.31 μM TE/mL, whereas that of T. bellerica was 29.17 μM TE/mL. The 
positive control (Quercetin) had the lowest IC50 value (12.16 μM TE/mL). Therefore, the 
results attribute T. chebula extracts with the highest oxygen radical absorption capacity. The 
ORAC assay is based upon the inhibition of the peroxyl-radical-induced oxidation initiated 
by thermal decomposition of azo-compounds such as [2,2’-azobis(2-amidino-propane) 
dihydrochloride (AAPH)].  
 Reactive oxygen species (ROS) are hazardous to cellular structures and functional 
molecules (i.e DNA, proteins, lipids) as they act as strong oxidizing mediators or free 
radicals. Biological antioxidants are able to dispose of ROS; as they are found to be safe and 
effective in eliminating all of the free radicals, oxygen ions and peroxides that can do 
damage to the body
7
. In this manner, the ORAC assay uses a biological relevant radical 
source and it combines both inhibition time and degree of inhibition into one quantity
21
.  
FRAP Assay 
The principle of a FRAP assay involves the reduction of ferric ions to ferrous ions by plant 
extracts due to the presence of reducing substances in the extracts
27. The extracts’ ability to 
reduce ferric ions was determined using the FRAP assay developed by Benzie and Strain
10
. 
Electron-donating antioxidant compounds are capable of reducing the ferric-TPTZ (Fe(III)-
TPTZ) complex to a blue ferrous-TPTZ (Fe(II)-TPTZ) complex that exhibits strong 
absorbance at 593 nm. Evaluation of the extracts’ ferric reducing antioxidant ability 
determined that the EC1 value of T. arjuna (232 µg/mL) was lower than that of T. chebula 
(243 µg/mL) and T. bellerica (265 µg/mL). The lower the EC1 value, the higher the ferric 
reducing antioxidant abilities of the extract. The BHT (3.2 µg/mL)  standard had greater 
ferric ion reducing capability than ascorbic acid (3.7 µg/mL) did. The reducing capacity of 
T. arjuna leaf extract may have been due to a large number of polyphenolic compounds with 
electron-donating hydroxyl groups. 
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Table 2. Antioxidant activities of Terminalia chebula, T. bellerica and T. arjuna methanolic 
leaf extracts in DPPH, ORAC and FRAP assays. 
No. Samples 
a
DPPH
  
IC50, 
µg/mL 
a 
ORAC IC50,  
μM/mL 
a
FRAP
  
EC1, 
μg/mL 
1 T. chebula 11.6±0.43 18.23±0.9 243±5.8 
2 T. bellerica 16.4±0.55 29.17±1.8 265±6.7 
3 T. arjuna 21.8±0.37 42.31±2.7 232±8.3 
4 Ascorbic acid 1.6±0.14 Not applicable 3.7±0.8 
5 BHT 1.7±0.07 Not applicable 3.2±0.5 
6 Quercetin Not applicable 12.16±1.3 Not applicable 
ORAC: Equivalent conc. Trolox (20 μg/mL) (μM) aDPPH, aORAC and aFRAP assays 
demonstrating low values indicate high antioxidant activity. Standard deviation (SD) 
values of a minimum of 3 replicates. 
 
 
In Vivo Study 
 
Acute Oral Toxicity Studies 
The leaf extracts of the 3 selected species were found to be non-toxic in rats, as neither 
mortality nor any considerable symptoms of toxicity were observed after oral administration 
of extracts at 2 dose levels (50 and 2500 mg/kg body weight) over a 72-hr period. 
 
Hypoglycemic Activity in Methanolic Leaf Extracts by Oral Route 
There was a reduction in blood glucose levels at 2 and 4 hr, with a slight increase at 6 h after 
oral administration of T. chebula, T. bellerica and T. arjuna leaf extracts. After 
glibenclamide administration, blood glucose levels were significantly reduced at 2, 4, as 
well as 6 h, but blood glucose levels did not change significantly within the different time 
intervals after oral administration of the negative control (0.9% NaCl). The results are listed 
in Table 3. There was a significant difference in blood glucose levels at 2, 4 and 6 h after 
oral administration of glibenclamide, T. chebula, T. bellerica, and T. arjuna extracts                   
(p <0.001) as compared to levels at 0 h and in the negative control (NaCl) group.  
 
 The control of postprandial hyperglycemia is one of the beneficial therapies for 
management of type 2 diabetes mellitus
28
, along with nutrition and oral hypoglycemic and 
insulin therapies
29
. In order to determine a scientific basis for the utilization of T. chebula, T. 
bellerica and T. arjuna leaves in the treatment of diabetes, we decided to evaluate their 
extracts’ hypoglycemic effect in normal rats. Earlier reports revealed that T. chebula and          
T. bellerica fruits and T. arjuna bark possessed antidiabetic effects when studied in STZ-
induced diabetic animals, and suggested that most diabetic complications were mediated 
through oxidative stress
30
. Production of ROS and its related oxidative stress was reported as 
the root cause for the development of insulin resistance, β-cell dysfunction, impaired 
glucose tolerance and type 2 diabetes mellitus
31
. The present study demonstrated that                
T. chebula leaf extract was more effective at decreasing blood glucose in normal rats, 
followed by T. bellerica and T. arjuna when compared to the negative control. This may be 
due to their flavonoid and phenolic contents, which are known to be involved in the healing 
process of free radical-mediated diseases, including diabetes
32
.  
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Time group, min 
Table 3. Hypoglycemic activity of methanolic leaf extracts by oral route in normal rats. 
 
Group 
 
Alteration in blood glucose levels (mmol/L) before and after 
administration of test samples (mean ± SD) 
0 h 2 h 4 h 6 h p-value 
NaCl control 7.5±0.32 7.1±0.23 6.6±0.37 6.7±0.28 0.059 
Glibenclamide 7.2±0.41 4.6±0.33
*
 4.5±0.24
*
 4.1±0.45
*
 <0.001 
T. chebula 6.9±0.37 5.4±0.26* 4.9±0.52
*
 5.1±0.31
*
 <0.001 
T. bellerica 6.6±0.29 4.9±0.17
*
 5.1±0.37
*
 5.4±0.46
*
 <0.001 
T. arjuna 7.0±0.36 5.8±0.24
*
 5.2±0.38
*
 5.7±0.29
*
 <0.001 
*Comparison with time 0 and negative control (NaCl) indicates significance (p <0.001). 
 
Oral Glucose Tolerance Test 
An oral glucose tolerance test was used to confirm the result of the hypoglycemic effects. 
The results depicted in Fig 1. indicate that there was no major alteration in blood glucose 
levels until 120 min following administration of extracts and NaCl in overnight-fasted 
normal rats. However, after 30 min of glucose load, blood glucose levels were considerably 
elevated in all treated groups up until 60 min, followed by a fall in glucose concentration 
until 120 min. Hence, there was a significant difference in blood glucose levels throughout 
the observation period for all 3 leaf extracts (p <0.001 when compared with the normal 
control group). This suggests that methanolic leaf extracts of Terminalia species have the 
ability to improve glucose tolerance activity in normal rats. This observation indicates that 
the extracts may interfere with the intestinal glucose absorption in the gut by various 
mechanism, this may be postulated that the positive results of these extracts might stimulates 
glycogenesis in the liver, which is enhanced by feeding and is hypothesized that the glucose 
tolerance activity induced by the extracts could be due to a mixture of active compounds that 
reduce the concentration of glucose and improve glucose tolerance activity
33-34
.  
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Figure 1. In normal fasted rats blood glucose levels, significantly changed at different time 
intervals after oral administration of extracts and glucose load (p <0.001). 
 
Conclusion 
The present study indicates that the leaf extracts of the selected Terminalia species possess 
antioxidant and hypoglycemic activities, which is probably due to their phenolic groups, and 
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brings new hope to research on the management of type 2 diabetic conditions. The use of 
these species as food supplements may aid in reduction of oxidative stress and related 
diabetic complications. However, the mechanism of action by which these species exert 
their action needs to be established by a thorough phytochemical investigation to identify the 
constituents responsible for the antioxidant and hypoglycemic activity. Furthermore, long-
term studies on type 2 diabetic models must be carried out to describe the exact mechanism 
of action at the cellular level. 
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